Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.43 |
| ▸ | GNG2 | P59768 | 2/20 | 0.43 |
| ▸ | GNB1 | P62873 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ROS1 | P08922 | 1/20 | 0.34 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.34 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5134183 | 0.92 | ALDH1A1 (0.43) | ALDH1A1KDM4EGNG2GNB1HSD17B10 | |
| SCHEMBL114129 | 0.91 | KDM4E (0.43) | ALDH1A1KDM4EGNG2GNB1HSD17B10 | |
| Hydrochloric Acid SCHEMBL27752560 | 0.90 | KDM4E (0.42) | ALDH1A1KDM4EGNG2GNB1HSD17B10 | |
| Hydrochloric Acid SCHEMBL30431952 | 0.90 | KDM4E (0.42) | ALDH1A1KDM4EGNG2GNB1HSD17B10 | |
| Sulfuric Acid SCHEMBL4915014 | 0.85 | KDM4E (0.41) | ALDH1A1KDM4EGNG2GNB1HSD17B10 | |
| SCHEMBL10048542 | 0.84 | APAF1 (0.41) | ALDH1A1KDM4EGNG2GNB1MAPT | |
| SCHEMBL13320813 | 0.84 | ALDH1A1 (0.46) | ALDH1A1KDM4EGNG2GNB1HSD17B10 | |
| SCHEMBL863067 | 0.81 | GNG2 (0.40) | ALDH1A1KDM4EGNG2GNB1MAPT | |
| SCHEMBL10045054 | 0.81 | S100B (0.46) | ALDH1A1KDM4EGNG2GNB1HSD17B10 | |
| SCHEMBL2849004 | 0.79 | GAA (0.40) | ALDH1A1KDM4EGNG2GNB1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9040700-B2 | Method of producing polymeric phenazonium compounds | CITIBANK, N.A. | 2015-05-26 | — | — | US | disclosed |
| US-20140163198-A1 | Method of Producing Polymeric Phenazonium Compounds | MACDERMID ACUMEN, INC. (US) | 2014-06-12 | — | — | US | disclosed |
| US-8735580-B2 | Method of producing polymeric phenazonium compounds | CITIBANK, N.A. | 2014-05-27 | — | — | US | disclosed |
| US-8691987-B2 | Method of producing polymeric phenazonium compounds | CITIBANK, N.A. | 2014-04-08 | — | — | US | disclosed |
| US-20120077956-A1 | Method of Producing Polymeric Phenazonium Compounds | CITIBANK, N.A. | 2012-03-29 | — | — | US | disclosed |
| US-20120073981-A1 | Method of Producing Polymeric Phenazonium Compounds | CITIBANK, N.A. | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120073981-A1 | Method of Producing Polymeric Phenazonium Compounds | NOX5, PRMT5, CHRM5 | ALDH1A1 2815/4885KDM4E 1175/4885GNG2 2135/4885 |
| US-20140163198-A1 | Method of Producing Polymeric Phenazonium Compounds | NOX5, PRMT5, H1-5 | ALDH1A1 2671/4885KDM4E 1276/4885GNG2 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.